Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | 08/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.18% | 35.99% | 30.08% | 23.42% | 6.16% |
| Total Depreciation and Amortization | -79.69% | -78.79% | -77.94% | -77.14% | -22.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.29% | -28.90% | 25.01% | 0.74% | 245.21% |
| Change in Net Operating Assets | 748.16% | 158.50% | 183.52% | 141.70% | 119.73% |
| Cash from Operations | 71.02% | 81.30% | 62.85% | 44.00% | 42.21% |
| Capital Expenditure | 13.82% | 18.54% | -29.77% | 41.01% | 57.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 9.61% | 14.82% | -39.05% | 39.21% | 59.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 48.84% |
| Issuance of Common Stock | -58.96% | -79.19% | -79.27% | -5.81% | -5.81% |
| Repurchase of Common Stock | -123.46% | -123.46% | -290.48% | -290.48% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 159.53% | 89.80% | 92.73% | 20.17% | -7.63% |
| Cash from Financing | -54.23% | -79.61% | -79.49% | -9.14% | -10.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.76% | 4.15% | -223.20% | 96.56% | 79.66% |
